AltruBio has roared back after another pivot in its twisty history, securing $225 million to test an immune checkpoint enhancer in ulcerative colitis.
Related Keywords
, Moon Fund , Francisco Based Altrubio , Cormorant Asset Management ,
comparemela.com © 2020. All Rights Reserved.